Stockscreener 앱 받기
3.14
0.63%
-0.02
시간 외 거래:
3.14
전일 마감가:
$3.16
열려 있는:
$3.14
하루 거래량:
223.39K
Relative Volume:
0.23
시가총액:
$97.46M
수익:
$62.30M
순이익/손실:
$-53.83M
주가수익비율:
-11.73
EPS:
-0.2677
순현금흐름:
$-30.14M
1주 성능:
-4.27%
1개월 성능:
-9.77%
6개월 성능:
-14.44%
1년 성능:
+82.56%
1일 변동 폭
$3.0815
$3.18
1주일 범위
$3.04
$3.31
52주 변동 폭
$1.325
$4.53
Fortress Biotech Inc Stock (FBIO) Company Profile
명칭
Fortress Biotech Inc
전화
781-652-4500
주소
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Compare FBIO vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
3.14 | 98.08M | 62.30M | -53.83M | -30.14M | -0.2677 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-15 | 재개 | ROTH MKM | Buy |
| 2022-08-04 | 개시 | Ladenburg Thalmann | Buy |
| 2020-10-02 | 개시 | The Benchmark Company | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2018-02-28 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | 개시 | Rodman & Renshaw | Buy |
| 2017-03-22 | 개시 | JMP Securities | Mkt Outperform |
| 2016-10-03 | 개시 | ROTH Capital | Buy |
모두보기
Fortress Biotech Inc 주식(FBIO)의 최신 뉴스
Mustang Bio (NASDAQ: MBIO) details GBM pipeline, Orphan status and cash - Stock Titan
Fortress Biotech (NASDAQ:FBIO) Cut to "Hold" at Zacks Research - MarketBeat
Fortress Biotech (NASDAQ:FBIO) Shares Pass Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Macro Review: How do insiders feel about Fortress Biotech IncMarket Movers & Verified Momentum Stock Alerts - baoquankhu1.vn
Understanding Momentum Shifts in (FBIOP) - Stock Traders Daily
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026 - GlobeNewswire
Fortress Biotech to Receive $205M as Cyprium Agrees Sale of Rare Pediatric Disease Priority Review Voucher - MSN
Quarterly Earnings: Should value investors consider Fortress Biotech Inc2026 Growth vs Value & Consistent Profit Trade Alerts - baoquankhu1.vn
Fortress Biotech Inc Stock (ISIN: US32015L1035) Faces Short Interest Pressure Amid Biotech Sector Vo - AD HOC NEWS
Fortress Biotech (NASDAQ:FBIO) Stock Price Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Swing Trade: How do insiders feel about Fortress Biotech IncCEO Change & Daily Technical Forecast Reports - baoquankhu1.vn
Avoiding Lag: Real-Time Signals in (FBIOP) Movement - Stock Traders Daily
Aug Sectors: How do insiders feel about Fortress Biotech IncMarket Performance Recap & Technical Entry and Exit Tips - baoquankhu1.vn
Aug Opening: What are the risks of holding Fortress Biotech IncJuly 2025 PreEarnings & Risk Controlled Swing Alerts - baoquankhu1.vn
FBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Weekly Trades: Will Fortress Biotech Inc outperform during market ralliesTreasury Yields & Technical Pattern Recognition Alerts - baoquankhu1.vn
Gap Down: Will Fortress Biotech Inc outperform during market ralliesNew Guidance & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Fortress Biotech (NASDAQ:FBIO) Stock Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Fortress Biotech (NASDAQ:FBIO) Stock Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Discipline and Rules-Based Execution in FBIOP Response - Stock Traders Daily
Fortress Biotech’s Cyprium enters agreement to sell PRV for $205M - Yahoo Finance
Fortress Biotech’s (FBIO) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
FBIO: HC Wainwright & Co. Reiterates Buy Rating on Fortress Biot - GuruFocus
FBIO Eyes Future Growth Amid Financial Optimism - StocksToTrade
FBIO Shares Rally After Unit Sells Priority Review Voucher For $205 Million: Retail Now Pins Hopes On Gene Therapy - Stocktwits
FBIO: HC Wainwright & Co. Reiterates Buy Rating on Fortress Biotech | FBIO Stock News - GuruFocus
Fortress Biotech Inc. Shares Soar After Promising New Developments - timothysykes.com
Fortress Biotech's (FBIO) Buy Rating Reiterated at HC Wainwright - MarketBeat
Fortress Biotech: PRV Windfall and De-Risked Zycubo Economics Support Buy Rating and $17 Target - TipRanks
Fortress Biotech (FBIO) Sells Priority Review Voucher for $205 M - GuruFocus
Fortress Biotech Inc. Faces Stock Volatility Amid Strategic Adjustments - StocksToTrade
Fortress Biotech, Inc. and Cyprium Therapeutics Enter Asset Purchase Agreement for $205 Million Rare Pediatric Disease Priority Review Voucher - Quiver Quantitative
UPDATE: Fortress Biotech’s Subsidiary Cyprium Therapeutics - GlobeNewswire
UPDATE: Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million - Yahoo Finance
Strategic Acquisition Sends Fortress Biotech Stocks Soaring - timothysykes.com
Fortress Biotech Subsidiary Agrees to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million - marketscreener.com
Cyprium Voucher Sale Bolsters Fortress Biotech Liquidity - TipRanks
Fortress Biotech Monetizes PRV for $205 Million; Amends Oaktree Credit Facility - TradingView
After Menkes drug approval, Fortress moves to cash in $205M voucher - Stock Titan
Avenue Therapeutics Enters into Exclusive Worldwide License - GlobeNewswire
Avenue Therapeutics Licenses ATX-04 for Pompe Disease - TipRanks
Gains Recap: What is Fortress Biotech Incs revenue forecastEarnings Performance Report & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Insider Trends: Can SVIIU navigate macro headwindsJuly 2025 Selloffs & Weekly Market Pulse Updates - baoquankhu1.vn
Fortress Biotech: The PRV Catalyst That Could Reprice This Microcap - Seeking Alpha
Fortress Biotech (NASDAQ:FBIO) Shares Cross Above 200-Day Moving Average – Here’s What Happened - Defense World
Fortress Biotech (NASDAQ:FBIO) Shares Cross Above 200-Day Moving AverageHere's What Happened - MarketBeat
Trade Report: Is Fortress Biotech Inc part of any ETFDividend Hike & Low Volatility Stock Recommendations - baoquankhu1.vn
MSN Money - MSN
Fortress Biotech amends credit agreement with Oaktree - MSN
Behavioral Patterns of FBIOP and Institutional Flows - Stock Traders Daily
What is Fortress Biotech Inc.’s book value per shareJuly 2025 Update & Reliable Intraday Trade Plans - mfd.ru
Fortress Biotech Inc (FBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):